This website is owned and operated by a private company - GovernmentGrant.com - Free Grant Money, Free Housing Grants, Free Personal Grants

Translational Research for the Development of Novel Interventions for Mental Disorders (R21/R33)

Post Date

March 24th 2011

Application Due Date

May 7th 2014

Funding Opportunity Number

PAR-11-177

CFDA Number(s)

93.242

Funding Instrument Type(s)

Grant

Funding Activity Categories

Health

Eligibility Categories

State Governments
County Governments
City or Township Governments
Special District Governments
Independent School Districts
Public and State Controlled Institutions of Higher Education
Federally Recognized Native American Tribal Governments
Public Housing Authorities or Indian Housing Authorities
Non-Federally Recognized Native American Tribal Organizations
Non-Profits With 501 (c) (3) Status With The IRS (Except Higher Education Institutions)
Non-Profits Without 501 (c) (3) Status With The IRS (Except Higher Education Institutions)
Private Institutions of Higher Education
For-Profit Organizations (Except Small Businesses)
Small Businesses
Other

Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Foreign (non-U.S.) components of U.S. Organizations are allowed.

Funding

  • Estimated Total Funding:

    $2000000

  • Award Range:

    $None - $None

Grant Description

This funding opportunity announcement (FOA) encourages Exploratory/Developmental Phased Innovation (R21/R33) grant applications to speed the translation of emerging findings on the neuroscience of mental disorders into novel intervention approaches that will ultimately reduce symptoms and/or restore function. This FOA provides support for up to two years (R21 phase) for preliminary, proof-of-principle studies in human participants, followed by up to 3 years of support (R33 phase) for pilot studies to assess the implementation of the intervention, and evaluate the feasibility of conducting a larger trial to assess the efficacy of the intervention. A range of non-pharmacologic treatment approaches will be accepted, including those based on neurophysiological, cognitive, affective, and/or social neuroscience models, basic behavioral science, and neurodevelopmental models. Applications submitted in response to this FOA must involve novel treatment targets, and/or novel and highly innovative approaches to engage and modify known targets.

Contact Information


Grant checklist

Get A Free Grant Assistance KitRed triangle

To start your application for a free grant package go to:

Apply For Government Grant